Successful Application of Closed-Loop Artificial Pancreas Therapy after Islet Autotransplantation

American Journal of Transplantation

Volumn 16, Issue 2, 2016, Pages 527-534

  Forlenza, Gregory P ^a,b   Nathan, B M ^a   Moran, A M ^a   Dunn, T B ^a   Beilman, G J ^a   Pruett, T L ^a   Bellin, M D ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

artificial organs; autotransplantation; clinical research; diabetology; endocrinology; islet transplantation; islets of Langerhans; practice; support devices; type 1

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN GLARGINE; SHORT ACTING INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; ARTIFICIAL PANCREAS; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN PUMP; INSULIN TREATMENT; MALE; PANCREAS ISLET BETA CELL; PANCREAS RESECTION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ANALYSIS; AUTOTRANSPLANTATION; CASE CONTROL STUDY; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; MIDDLE AGED; PANCREAS ISLET TRANSPLANTATION; PANCREATITIS, CHRONIC; PILOT STUDY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RISK FACTOR; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; HYPOGLYCEMIA; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS, ARTIFICIAL; PANCREATECTOMY; PANCREATITIS, CHRONIC; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTORS; TRANSPLANTATION, AUTOLOGOUS; YOUNG ADULT;

EID: 84957967287     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13539     Document Type: Article

References (37)

1. Hathout E, Chan NK, Tan A, et al., In vivo imaging demonstrates a time-line for new vessel formation in islet transplantation. Pediatr Transplant 2009; 13: 892-897.
2. Speier S, Nyqvist D, Cabrera O, et al., Noninvasive in vivo imaging of pancreatic islet cell biology. Nat Med 2008; 14: 574-578.
3. Finzi G, Davalli A, Placidi C, et al., Morphological and ultrastructural features of human islet grafts performed in diabetic nude mice. Ultrastruct Pathol 2005; 29: 525-533.
4. Nacher V, Merino JF, Raurell M, Soler J, Montanya E., Normoglycemia restores beta-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia. Diabetes 1998; 47: 192-196.
5. Biarnes M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E., Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002; 51: 66-72.
6. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC., Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes 1996; 45: 1161-1167.
7. Juang JH, Bonner-Weir S, Wu YJ, Weir GC., Beneficial influence of glycemic control upon the growth and function of transplanted islets. Diabetes 1994; 43: 1334-1339.
8. Jimbo T, Inagaki A, Imura T, et al., A novel resting strategy for improving islet engraftment in the liver. Transplantation 2014; 97: 280-286.
9. Merino JF, Nacher V, Raurell M, Biarnes M, Soler J, Montanya E., Optimal insulin treatment in syngeneic islet transplantation. Cell Transplant 2000; 9: 11-18.
10. Ferrer-Garcia JC, Merino-Torres JF, Perez Bermejo G, Herrera-Vela C, Ponce-Marco JL, Pinon-Selles F,. Insulin-induced normoglycemia reduces islet number needed to achieve normoglycemia after allogeneic islet transplantation in diabetic mice. Cell Transplant 2003; 12: 849-857.
11. Bellin MD, Sutherland DE, Chinnakotla S, et al., Insulin independence after islet autotransplant is associated with subtle differences in early post-transplant glycemic control. Diabetes 2012; 61 (Suppl 1): A43.
12. Forlenza GP, Chinnakotla S, Schwarzenberg SJ, et al., Near-euglycemia can be achieved safely in pediatric total pancreatectomy islet autotransplant recipients using an adapted intravenous insulin infusion protocol. Diabetes Technol Ther 2014; 16: 706-713.
13. Yadav D, Timmons L, Benson JT, Dierkhising RA, Chari ST., Incidence, prevalence, and survival of chronic pancreatitis: A population-based study. Am J Gastroenterol 2011; 106: 2192-2199.
14. Steer ML, Waxman I, Freedman S., Chronic pancreatitis. N Engl J Med 1995; 332: 1482-1490.
15. Muniraj T, Aslanian HR, Farrell J, Jamidar PA., Chronic pancreatitis, a comprehensive review and update. Part II: Diagnosis, complications, and management. Dis Mon 2015; 61: 5-37.
16. Robertson RP., Islet transplantation for type 1 diabetes, 2015: What have we learned from alloislet and autoislet successes ? Diabetes Care 2015; 38: 1030-1035.
17. Shah VN, Shoskes A, Tawfik B, Garg SK., Closed-loop system in the management of diabetes: Past, present, and future. Diabetes Technol Ther 2014; 16: 477-490.
18. Ruiz JL, Sherr JL, Cengiz E, et al., Effect of insulin feedback on closed-loop glucose control: A crossover study. J Diabetes Sci Technol 2012; 6: 1123-1130.
19. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF., Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006; 55: 3344-3350.
20. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV., Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008; 31: 934-939.
21. Bellin MD, Sutherland DE., Pediatric islet autotransplantation: Indication, technique, and outcome. Curr Diab Rep 2010; 10: 326-331.
22. Farney AC, Najarian JS, Nakhleh RE, et al., Autotransplantation of dispersed pancreatic islet tissue combined with total or near-total pancreatectomy for treatment of chronic pancreatitis. Surgery 1991; 110: 427-437.
23. Lakey JR, Warnock GL, Ao Z, et al., Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Transplant Proc 1998; 30: 359.
24. Ricordi C, Lacy PE, Scharp DW., Automated islet isolation from human pancreas. Diabetes 1989; 38 (Suppl 1): 140-142.
25. Basu A, Dube S, Veettil S, et al., Time lag of glucose from intravascular to interstitial compartment in type 1 diabetes. J Diabetes Sci Technol 2015; 9: 63-68.
26. Basu A, Dube S, Slama M, et al., Time lag of glucose from intravascular to interstitial compartment in humans. Diabetes 2013; 62: 4083-4087.
27. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG., Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42: 377-381.
28. Chinnakotla S, Radosevich DM, Dunn TB, et al., Long-term outcomes of total pancreatectomy and islet auto transplantation for hereditary/genetic pancreatitis. J Am Coll Surg 2014; 218: 530-543.
29. Bellin MD, Sutherland DE, Beilman GJ, et al., Similar islet function in islet allotransplant and autotransplant recipients, despite lower islet mass in autotransplants. Transplantation 2011; 91: 367-372.
30. Rickels MR, Liu C, Shlansky-Goldberg RD, et al., Improvement in beta-cell secretory capacity after human islet transplantation according to the CIT07 protocol. Diabetes 2013; 62: 2890-2897.
31. O'Grady MJ, Retterath AJ, Keenan DB, et al., The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012; 35: 2182-2187.
32. Elleri D, Allen JM, Biagioni M, et al., Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pediatr Diabetes 2012; 13: 449-453.
33. Buckingham B, Beck RW, Ruedy KJ, et al., Effectiveness of early intensive therapy on beta-cell preservation in type 1 diabetes. Diabetes Care 2013; 36: 4030-4035.
34. Coronel MM, Stabler CL., Engineering a local microenvironment for pancreatic islet replacement. Curr Opin Biotechnol 2013; 24: 900-908.
35. Robles L, Storrs R, Lamb M, Alexander M, Lakey JR., Current status of islet encapsulation. Cell Transplant 2014; 23: 1321-1348.
36. Weir GC., Islet encapsulation: Advances and obstacles. Diabetologia 2013; 56: 1458-1461.
37. Yang EY, Kronenfeld JP, Stabler CL,. Engineering biomimetic materials for islet transplantation. Curr Diabetes Rev 2015; 11: 163-169.